Biomarkers for predicting nucleos(t)ide analogs discontinuation and hepatitis B virus recurrence after drug withdrawal in chronic hepatitis B patients

被引：10

作者：

Luo, Mengqi ^{[1
]}

Zhou, Bin ^{[1
]}

Hou, Jinlin ^{[1
]}

Jiang, Deke ^{[1
]}

机构：

[1] Southern Med Univ, Dept Infect Dis & Hepatol Unit, State Key Lab Organ Failure Res,Nanfang Hosp, Guangdong Key Lab Viral Hepatitis Res,Inst Liver, Guangzhou 510515, Peoples R China

来源：

HEPATOLOGY RESEARCH | 2022年 / 52卷 / 04期

基金：

中国国家自然科学基金;

关键词：

chronic; Hepatitis B; predict; withdrawal; CORE-RELATED ANTIGEN; SERUM HBV RNA; HBEAG-NEGATIVE PATIENTS; LONG-TERM TREATMENT; PROTEIN; 10; SERUM; SURFACE-ANTIGEN; ENTECAVIR THERAPY; CLINICAL-OUTCOMES; OFF-TREATMENT; LAMIVUDINE TREATMENT;

D O I：

10.1111/hepr.13749

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Aim To summarize HBV-related biomarkers predicting nucleos(t)ide analogs (NAs) discontinuation and hepatitis B virus (HBV) recurrence after drug withdrawal in chronic hepatitis B (CHB) patients, providing references for clinical medication, so as to manage CHB patients more scientifically. Methods Related pieces of literature were retrieved in PubMed and the results were sorted out. We then analyzed and summarized these articles. Results We found that HBV related biomarkers maybe could predict NAs withdrawal safely and the possibility of relapse after treatment cessation, including hepatitis B e antigen (HBeAg), hepatitis B surface antigen (HBsAg), HBV DNA, HBV RNA, pregenomic-RNA (pgRNA), hepatitis B core-related antigen (HBcrAg), hepatitis B core antibody (anti-HBc), and models containing several indicators for predicting the effectiveness of treatment. Conclusions HBV DNA, HBV RNA, pgRNA, HBcrAg, anti-HBc, as well as the prediction models formed by several biomarkers could predict the safe discontinuation of NAs before HBsAg loss and recurrence.

引用

页码：337 / 351

页数：15

共 98 条

[21] Durability of Hepatitis B e Antigen Seroconversion in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir [J].

Fong, Tse-Ling ;

Tien, Andy ;

Jo, Kahee J. ;

Chu, Danny ;

Cheung, Eddie ;

Mena, Edward A. ;

Quang-Quoc Phan ;

Yu, Andy S. ;

Mohammed, Wafa ;

Velasco, Andrew ;

Vinh-Huy LeDuc ;

Nguyen, Nickolas ;

Han, Steven-Bui ;

Chang, Mimi ;

Bae, Ho S. ;

Cho, Yong-Won ;

Tong, Myron J. ;

Cooper, Stewart L. .

DIGESTIVE DISEASES AND SCIENCES, 2015, 60 (11) :3465-3472

[22] 48 weeks outcome after cessation of nucleos(t)ide analogue therapy in chronic hepatitis B patients [J].

Gao, Li ;

Hu, Yue ;

Shi, Xiaofeng ;

Li, Xin ;

Zhang, Dazhi ;

Ren, Hong .

ANNALS OF HEPATOLOGY, 2020, 19 (03) :329-334

[23] A novel one-step quantitative reverse transcription PCR assay for selective amplification of hepatitis B virus pregenomic RNA from a mixture of HBV DNA and RNA in serum [J].

Gao, Ming ;

Feng, Chengqian ;

Ying, Ruosu ;

Nie, Yuan ;

Deng, Xizi ;

Zhu, Ying ;

Tang, Xiaoping ;

Guan, Yujuan ;

Hu, Fengyu ;

Li, Feng .

ARCHIVES OF VIROLOGY, 2019, 164 (11) :2683-2690

[24] Viral and immune factors associated with successful treatment withdrawal in HBeAg-negative chronic hepatitis B patients [J].

Garcia-Lopez, Mireia ;

Lens, Sabela ;

Pallett, Laura J. ;

Testoni, Barbara ;

Rodriguez-Tajes, Sergio ;

Marino, Zoe ;

Bartres, Concepcion ;

Garcia-Pras, Ester ;

Leonel, Thais ;

Perpinan, Elena ;

Lozano, Juan Jose ;

Rodriguez-Frias, Francisco ;

Koutsoudakis, George ;

Zoulim, Fabien ;

Maini, Mala K. ;

Forns, Xavier ;

Perez-del-Pulgar, Sofia .

JOURNAL OF HEPATOLOGY, 2021, 74 (05) :1064-1074

[25] Hepatitis B surface antigen levels of cessation of nucleos(t)ide analogs associated with virological relapse in hepatitis B surface antigen-negative chronic hepatitis B patients [J].

Ge, Guo-Hong ;

Ye, Yun ;

Zhou, Xin-Bei ;

Chen, Li ;

He, Cong ;

Wen, Dan-Feng ;

Tan, You-Wen .

WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (28) :8653-8659

[26] Serum HBV pgRNA as a clinical marker for cccDNA activity [J].

Giersch, Katja ;

Allweiss, Lena ;

Volz, Tassilo ;

Dandrilz, Maura ;

Luetgehetmann, Marc .

JOURNAL OF HEPATOLOGY, 2017, 66 (02) :460-462

[27] Sustained Responses and Loss of HBsAg in HBeAg-Negative Patients With Chronic Hepatitis B Who Stop Long-Term Treatment With Adefovir [J].

Hadziyannis, Stephanos J. ;

Sevastianos, Vassilios ;

Rapti, Irene ;

Vassilopoulos, Dimitrios ;

Hadziyannis, Emilia .

GASTROENTEROLOGY, 2012, 143 (03) :629-U115

[28] Combining hepatitis B core-related and surface antigens at end of nucleos(t)ide analogue treatment to predict off-therapy relapse risk [J].

Hsu, Yao-Chun ;

Nguyen, Mindie H. ;

Mo, Lein-Ray ;

Wu, Ming-Shiang ;

Yang, Tzeng-Huey ;

Chen, Chieh-Chang ;

Tseng, Cheng-Hao ;

Tai, Chi-Ming ;

Wu, Chun-Ying ;

Lin, Jaw-Town ;

Tanaka, Yasuhito ;

Chang, Chi-Yang .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 49 (01) :107-115

[29] Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen-Negative Patients [J].

Hsu, Yao-Chun ;

Mo, Lein-Ray ;

Chang, Chi-Yang ;

Wu, Ming-Shiang ;

Kao, Jia-Horng ;

Wang, Wen-Lun ;

Yang, Tzeng-Huey ;

Wang, Chaur-Shine ;

Chiang, Ming-Feng ;

Chen, Chieh-Chang ;

Fang, Yu-Jen ;

Hung, Hsu-Wei ;

Wu, Chun-Ying ;

Lin, Jaw-Town .

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (10) :1490-+

[30] Hepatitis B surface antigen loss and clinical outcomes between HBeAg-negative cirrhosis patients who discontinued or continued nucleoside analogue therapy [J].

Hung, C. -H. ;

Wang, J. -H. ;

Lu, S. -N. ;

Hu, T. -H. ;

Lee, C. -M. ;

Chen, C. -H. .

JOURNAL OF VIRAL HEPATITIS, 2017, 24 (07) :599-607

← 1 2 3 4 5 6 7 8 9 10 →